Takeda Pharmaceutical

$17.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.29 (+1.71%) As of 5:26 PM UTC today

Why Robinhood?

You can buy or sell TAK and other stocks, options, and ETFs commission-free!

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. The listed name for TAK is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share o.

CEO

Christophe Weber

Employees

47,495

Headquarters

Osaka, Osaka

Founded

1781

Market Cap

56.00B

Price-Earnings Ratio

30.60

Dividend Yield

4.19

Average Volume

4.43M

High Today

$17.03

Low Today

$16.90

Open Price

$16.93

Volume

1.40M

52 Week High

$20.00

52 Week Low

$12.43

TAK News

ReutersFeb 24

UPDATE 1-Takeda says first patient given Novavax COVID-19 vaccine in Japan clinical trial

(Adds details from second paragraph.) TOKYO, Feb 24 (Reuters) - Takeda Pharmaceutical Co said on Wednesday the first patient had been given Novavax Inc's COVID

Analyst Ratings

85%

of 13 ratings

Buy

85%

Hold

15%

Sell

TAK Earnings

$0.00

$0.39

$0.79

$1.18

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available May 11, Pre-Market